Daxor posts new investor presentation on 8-K

Q: Who signed this Daxor Corporation (DXR) 8-K filing?

The 8-K was signed on behalf of Daxor Corporation by Robert J. Michel, Chief Financial Officer.

Daxor Corporation filed a current report to share its latest investor presentation with the market.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Daxor Corporation filed a current report to share its latest investor presentation with the market. The company used an 8-K under the "Other Events" section to formally furnish this material.

The filing states that the current investor presentation is attached as Exhibit 99.1, making it part of the public record. Daxor’s common stock, with a par value of $0.01 per share, trades on Nasdaq under the symbol DXR.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Daxor Corporation (DXR) report in this 8-K filing?

Daxor Corporation reported that its current investor presentation is being furnished as Exhibit 99.1 under the "Other Events" section.

What is included as Exhibit 99.1 in Daxor (DXR)'s 8-K?

Exhibit 99.1 consists of Daxor Corporation’s current investor presentation, which is attached to the 8-K.

Under which item of the 8-K did Daxor (DXR) provide the investor presentation?

The investor presentation is furnished under Item 8.01, labeled "Other Events."

On which exchange is Daxor Corporation (DXR) common stock listed?

Daxor Corporation’s common stock, $0.01 par value, is listed on the Nasdaq under the trading symbol DXR.

Who signed this Daxor Corporation (DXR) 8-K filing?

The 8-K was signed on behalf of Daxor Corporation by Robert J. Michel, Chief Financial Officer.

What other exhibit is referenced in this Daxor (DXR) 8-K?

The filing also references Exhibit 104, the Cover Page Interactive Data File embedded within the Inline XBRL document.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 01/23/2026 - 06:09 AM EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) January 23, 2026

Daxor Corporation

(Exact name of registrant as specified in its charter)

New York

811-22684

13-2682108

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

107 Meco Lane, Oak Ridge, TN		37830
(Address of principal executive offices)		(Zip Code)

212-330-8500

Registrant’s telephone number, including area code

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock $0.01 par value		DXR		Nasdaq

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Item 8.01 – Other Events

Attached hereto as Exhibit 99.1 is Daxor Corporation’s current investor presentation.

Item 9.01 Exhibits

(d)

Exhibits. The following exhibit is filed with this Current Report on Form 8-K:

No.		Description

99.1		Attached hereto is an investor presentation.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	DAXOR CORPORATION
	(Registrant)

Date: January 23, 2026	By:	/s/ Robert J. Michel
	Name:	Robert J. Michel
	Title:	Chief Financial Officer

Source: View Original Filing on SEC EDGAR